These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 30830240)

  • 21. Brain Cholesterol Synthesis and Metabolism is Progressively Disturbed in the R6/1 Mouse Model of Huntington's Disease: A Targeted GC-MS/MS Sterol Analysis.
    Kreilaus F; Spiro AS; Hannan AJ; Garner B; Jenner AM
    J Huntingtons Dis; 2015; 4(4):305-18. PubMed ID: 26639223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic analysis reveals evidence for branched chain amino acid catabolism crosstalk and the potential for improved treatment of organic acidurias.
    McCalley S; Pirman D; Clasquin M; Johnson K; Jin S; Vockley J
    Mol Genet Metab; 2019; 128(1-2):57-61. PubMed ID: 31133529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Caloric restriction improves glycaemic control without reducing plasma branched-chain amino acids or keto-acids in obese men.
    Sayda MH; Abdul Aziz MH; Gharahdaghi N; Wilkinson DJ; Greenhaff PL; Phillips BE; Smith K; Idris I; Atherton PJ
    Sci Rep; 2022 Nov; 12(1):19273. PubMed ID: 36369511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiplatform metabolomic analysis of the R6/2 mouse model of Huntington's disease.
    Hashimoto M; Watanabe K; Miyoshi K; Koyanagi Y; Tadano J; Miyawaki I
    FEBS Open Bio; 2021 Oct; 11(10):2807-2818. PubMed ID: 34469070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of leucine supplementation and serum withdrawal on branched-chain amino acid pathway gene and protein expression in mouse adipocytes.
    Kitsy A; Carney S; Vivar JC; Knight MS; Pointer MA; Gwathmey JK; Ghosh S
    PLoS One; 2014; 9(7):e102615. PubMed ID: 25050624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Duplication and Functional Divergence of Branched-Chain Amino Acid Biosynthesis Genes in Aspergillus nidulans.
    Steyer JT; Downes DJ; Hunter CC; Migeon PA; Todd RB
    mBio; 2021 Jun; 12(3):e0076821. PubMed ID: 34154419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defect of branched-chain amino acid metabolism promotes the development of Alzheimer's disease by targeting the mTOR signaling.
    Li H; Ye D; Xie W; Hua F; Yang Y; Wu J; Gu A; Ren Y; Mao K
    Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29802157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leptin deficiency reverses high metabolic state and weight loss without affecting central pathology in the R6/2 mouse model of Huntington's disease.
    Sjögren M; Soylu-Kucharz R; Dandunna U; Stan TL; Cavalera M; Sandelius Å; Zetterberg H; Björkqvist M
    Neurobiol Dis; 2019 Dec; 132():104560. PubMed ID: 31419548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Branched-chain amino acid metabolism, insulin sensitivity and liver fat response to exercise training in sedentary dysglycaemic and normoglycaemic men.
    Lee S; Gulseth HL; Langleite TM; Norheim F; Olsen T; Refsum H; Jensen J; Birkeland KI; Drevon CA
    Diabetologia; 2021 Feb; 64(2):410-423. PubMed ID: 33123769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deletion of equilibrative nucleoside transporter 2 disturbs energy metabolism and exacerbates disease progression in an experimental model of Huntington's disease.
    Chen CY; Chou FY; Chang YG; Ho CJ; Wu KC; Hsu CL; Chern Y; Lin CJ
    Neurobiol Dis; 2023 Feb; 177():106004. PubMed ID: 36669543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acetolactate synthase regulatory subunits play divergent and overlapping roles in branched-chain amino acid synthesis and Arabidopsis development.
    Dezfulian MH; Foreman C; Jalili E; Pal M; Dhaliwal RK; Roberto DK; Imre KM; Kohalmi SE; Crosby WL
    BMC Plant Biol; 2017 Apr; 17(1):71. PubMed ID: 28388946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxidative metabolism and Ca2+ handling in isolated brain mitochondria and striatal neurons from R6/2 mice, a model of Huntington's disease.
    Hamilton J; Pellman JJ; Brustovetsky T; Harris RA; Brustovetsky N
    Hum Mol Genet; 2016 Jul; 25(13):2762-2775. PubMed ID: 27131346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Branched-Chain Amino Acids and Brain Metabolism.
    Sperringer JE; Addington A; Hutson SM
    Neurochem Res; 2017 Jun; 42(6):1697-1709. PubMed ID: 28417264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multivariate Box-Behnken assessment of elevated branched-chain amino acid concentrations in reduced crude protein diets offered to male broiler chickens.
    Chrystal PV; Greenhalgh S; Macelline SP; Dorigam JCP; Selle PH; Liu SY
    PLoS One; 2022; 17(3):e0266080. PubMed ID: 35353869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. OLIVe: A Genetically Encoded Fluorescent Biosensor for Quantitative Imaging of Branched-Chain Amino Acid Levels inside Single Living Cells.
    Yoshida T; Nakajima H; Takahashi S; Kakizuka A; Imamura H
    ACS Sens; 2019 Dec; 4(12):3333-3342. PubMed ID: 31845569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic flux analysis of branched-chain amino and keto acids (BCAA, BCKA) and β-hydroxy β-methylbutyric acid across multiple organs in the pig.
    Ten Have GAM; Jansen L; Schooneman MG; Engelen MPKJ; Deutz NEP
    Am J Physiol Endocrinol Metab; 2021 Mar; 320(3):E629-E640. PubMed ID: 33522397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrative Characterization of the R6/2 Mouse Model of Huntington's Disease Reveals Dysfunctional Astrocyte Metabolism.
    Skotte NH; Andersen JV; Santos A; Aldana BI; Willert CW; Nørremølle A; Waagepetersen HS; Nielsen ML
    Cell Rep; 2018 May; 23(7):2211-2224. PubMed ID: 29768217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microglial physiological properties and interactions with synapses are altered at presymptomatic stages in a mouse model of Huntington's disease pathology.
    Savage JC; St-Pierre MK; Carrier M; El Hajj H; Novak SW; Sanchez MG; Cicchetti F; Tremblay MÈ
    J Neuroinflammation; 2020 Apr; 17(1):98. PubMed ID: 32241286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. R6/2 Huntington's disease mice develop early and progressive abnormal brain metabolism and seizures.
    Cepeda-Prado E; Popp S; Khan U; Stefanov D; Rodríguez J; Menalled LB; Dow-Edwards D; Small SA; Moreno H
    J Neurosci; 2012 May; 32(19):6456-67. PubMed ID: 22573668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypothalamic expression of huntingtin causes distinct metabolic changes in Huntington's disease mice.
    Dickson E; Soylu-Kucharz R; Petersén Å; Björkqvist M
    Mol Metab; 2022 Mar; 57():101439. PubMed ID: 35007790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.